<DOC>
	<DOCNO>NCT00001013</DOCNO>
	<brief_summary>To compare safety effectiveness investigational drug therapy ( trimetrexate plus leucovorin calcium ) conventional therapy ( sulfamethoxazole-trimethoprim ) treatment moderately severe Pneumocystis carinii pneumonia ( PCP ) patient AIDS , HIV positive , high risk HIV infection .</brief_summary>
	<brief_title>Comparison Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim Treatment Pneumocystis Carinii Pneumonia ( PCP ) Patients With AIDS</brief_title>
	<detailed_description>New treatment need reduce mortality rate PCP AIDS patient reduce high relapse rate find conventional therapy . Trimetrexate ( TMTX ) choose trial find much potent sulfamethoxazole/trimethoprim ( SMX/TMP ) PCP organism laboratory test . Also TMTX , combination leucovorin ( LCV ) , cause severe toxicity preliminary trial . It believe TMTX effective SMX/TMP treat PCP prevent recurrence PCP . Preliminary study suggest aerosolize pentamidine ( PEN ) likely effective prevent recurrence PCP . Patients enter study randomly assign TMTX / LCV SMX/TMP 21-day trial . For first 10 day , trial double-blind ( neither patient physician know drug patient receive ) , drug give intravenous infusion . TMTX give every 24 hour LCV every 6 hour ; SMX/TMP give every 6 hour . Doses determine body size . After first 10 day , LCV SMX/TMP may give orally . Doses adjust treatment change intravenous PEN side effect severe . During 21-day trial , zidovudine ( AZT ) may use possible increase bone marrow toxicity . AZT may resume soon patient 's white cell count acceptable . Aerosolized PEN therapy begin 7 - 10 day completion therapy acute episode . PEN inhale weekly 4 week , every 2 week 48 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<mesh_term>Trimetrexate</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Acetaminophen : 650 mg prescribe necessary temperature &gt; 38.7 degree C. Acetaminophen prescribe stand order 48 hour . Prior Medication : Allowed : Zidovudine ( AZT ) long therapy suspend prior randomization reinstituted therapy acute episode complete patient 's white blood cell count acceptable . Other myelosuppressive therapy may handle manner AZT . Prophylaxis Pneumocystis carinii pneumonia ( PCP ) . Unequivocal diagnosis Pneumocystis carinii pneumonia ( PCP ) morphologic confirmation three typical P. carinii organism sputum , bronchoalveolar lavage fluid , lung tissue obtain transbronchial openlung biopsy within 3 day randomization . If morphologic confirmation possible prior therapy , patient may randomize investigator believe high suspicion PCP base clinical presentation . If morphologic diagnosis establish within 6 day randomization , patient withdrawn study therapy . Resting ( Aa ) DO2 &lt; 30 torr room air . Patient , parent , guardian , person power attorney give informed consent . Exclusion Criteria Coexisting Condition : Patients exclude follow reason : History Type I hypersensitivity ( i.e. , urticaria , angioedema , anaphylaxis ) , exfoliative dermatitis , lifethreatening reaction secondary antibiotic contain sulfa , trimethoprim , trimetrexate . History lifethreatening pentamidine toxicity . Concurrent Medication : Excluded : Other drug treatment prevention AIDS Pneumocystis carinii pneumonia ( PCP ) . Disalcid . Aspirin . Acetaminophen q4h stand order 48 hour . Prior Medication : Excluded within 14 day study entry : Systemic steroid exceed physiological replacement . Other investigational drug include ganciclovir . Excluded within 6 week study entry : Another antiprotozoal regimen episode therapy active Pneumocystis carinii pneumonia ( PCP ) . Patients unable arterial blood gas analysis ( ABG 's ) room air . Patients liter intravenous fluid ( 5 percent dextrose water ) per 24 hour , require maintain blinding , would medically inadvisable .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Trimethoprim-Sulfamethoxazole Combination</keyword>
	<keyword>Trimetrexate</keyword>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Infusions , Intravenous</keyword>
	<keyword>Leucovorin</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Folic Acid Antagonists</keyword>
	<keyword>Aerosols</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Antiprotozoal Agents</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Sulfamethoxazole-Trimethoprim</keyword>
</DOC>